Carol Schafer
Director/Board Member en REPARE THERAPEUTICS INC. .
Fortuna: 505 944 $ al 31/03/2024
Perfil
Ms. Carol A.
Schafer is an Independent Director at Immunome, Inc., an Independent Director at Kura Oncology, Inc., an Independent Director at Insmed, Inc., an Independent Director at Repare Therapeutics, Inc. and a Managing Partner at Hyphen Advisors LLC.
She is on the Board of Directors at Immunome, Inc., Kura Oncology, Inc., Insmed, Inc., Onegoal New York and Repare Therapeutics, Inc. Ms. Schafer was previously employed as an Independent Director by Five Prime Therapeutics, Inc., an Independent Director by Idera Pharmaceuticals, Inc., a Vice Chairman-Equity Capital Markets by Wells Fargo Securities LLC, a VP-Finance, Business Development & Communications by Lexicon Genetics, Inc., and a MD, VP & Head-Equity Capital Markets by J.P.
Morgan & Co., Inc. (Old).
She received her undergraduate degree from Boston College and an MBA from The Leonard N Stern School of Business.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
INSMED INCORPORATED
0.01% | 11/05/2023 | 17 260 ( 0.01% ) | 468 264 $ | 31/03/2024 |
REPARE THERAPEUTICS INC.
0.02% | 08/06/2023 | 8 000 ( 0.02% ) | 37 680 $ | 31/03/2024 |
IMMUNOME, INC.
-.--% | 02/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
KURA ONCOLOGY, INC.
-.--% | 31/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Carol Schafer
Empresas | Cargo | Inicio |
---|---|---|
REPARE THERAPEUTICS INC. | Director/Board Member | 01/03/2019 |
INSMED INCORPORATED | Director/Board Member | 01/04/2020 |
KURA ONCOLOGY, INC. | Director/Board Member | 03/06/2021 |
IMMUNOME, INC. | Director/Board Member | 02/01/2024 |
Hyphen Advisors LLC | Chief Executive Officer | 01/01/2018 |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Onegoal New York operates a social services organization. The private company is based in New York. | Director/Board Member | 01/03/2019 |
Antiguos cargos conocidos de Carol Schafer.
Empresas | Cargo | Fin |
---|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Director/Board Member | 28/09/2022 |
FIVE PRIME THERAPEUTICS, INC. | Director/Board Member | 16/04/2021 |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Corporate Officer/Principal | 01/09/2018 |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Carol Schafer.
Boston College | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
INSMED INCORPORATED | Health Technology |
IMMUNOME, INC. | Health Technology |
KURA ONCOLOGY, INC. | Health Technology |
Empresas privadas | 7 |
---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
J.P. Morgan & Co., Inc. (Old) | Finance |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Finance |
Repare Therapeutics, Inc. | |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Onegoal New York operates a social services organization. The private company is based in New York. | Commercial Services |
Hyphen Advisors LLC |
- Bolsa de valores
- Insiders
- Carol Schafer